Defunct Company
Total Trials
12
As Lead Sponsor
9
As Collaborator
3
Total Enrollment
5,021
NCT01955954
Using the Canary Breathing System for Panic Disorder Patients
Phase: N/A
Role: Lead Sponsor
Start: Sep 30, 2013
Completion: May 31, 2016
NCT03312049
Aflatoxin Birth Cohort Study Nepal (AflaCohort)
Role: Collaborator
Start: Jul 6, 2015
Completion: Mar 31, 2019
NCT02385513
PCV10 Immunogenicity Study Nepal 2015
Phase: Phase 4
Start: Aug 21, 2015
Completion: Feb 23, 2017
NCT02998502
The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens
Start: Sep 30, 2016
Completion: Feb 1, 2021
NCT02949141
Diagnostic Use of Lung Ultrasound for Suspected Pneumonia in Nepal
Start: Nov 30, 2016
Completion: May 1, 2017
NCT03039231
Investigation of the Freespira Breathing System in the Treatment of Post Traumatic Stress Disorder (PTSD)
Start: Feb 1, 2017
Completion: Aug 25, 2019
NCT03630380
Accuracy of Clinical and Diagnostic Studies for Pneumonia in Children
Start: Jun 1, 2018
Completion: Jul 31, 2020
NCT05292508
Comparison of Rates of Antimicrobial Use in Febrile Patients With or Without the Use of C-reactive Protein Blood Test
Start: Feb 26, 2023
Completion: Dec 31, 2023
NCT06304272
Comparison Between Drinking Water and Normal Saline in Irrigating Traumatic Wound
Start: Mar 31, 2024
Completion: Dec 31, 2027
NCT06327867
Comparison of Video Laryngoscopy Versus Direct Laryngoscopy for Orotracheal Intubation Among Adults in Emergency Department
Start: May 1, 2024
Completion: May 1, 2025
NCT06936007
Hematological Manifestations in Systemic Lupus Erythematosus Patients
Start: Nov 1, 2024
Completion: Dec 30, 2024
NCT07004751
Etiology of Febrile Illness in Nepal (DEFINe Study)
Start: Jul 4, 2025
Completion: Oct 1, 2026